Дозирование твердых веществ

Средства противоопухолевой терапии

The global market for cancer drugs has recently reached an annual sales value of $100 billion — including therapeutic treatments and supportive care — and the market could be worth $147 billion by 2018, driven by earlier diagnosis, longer-term treatments and the increased efficacy of novel drug therapies.

With the rise in immuno-oncology applications, innovative combination therapies and the pursuit of genetic targets across multiple tumors, it is predicted that, by 2020, most oncology drugs will carry multiple indications. The safe, efficient and cost-effective production of oral solid dosage forms to treat cancer has never been more critical for pharmaceutical manufacturers.

The GEA Solution

GEA can supply a specialized solution when no standard off-the-shelf one exists, particularly for toxic or highly potent cytostatics and oncology drugs. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.

Experts in aseptic process management, closed product handling, compliance with cGMP requirements, gentle product treatment, the efficient recovery of active ingredients and reliable scale-up, we supply modules, components and complete lines for the production of oncology drugs and other therapeutic agents. 

From R&D-scale and standalone production equipment to completely integrated and fully contained production lines, we understand the absolute importance of preventing cross-contamination in the production area, eliminating operator exposure to hazardous substances and working within Real Daily Intake (RDI) and Acceptable Daily Intake (ADI) limits with occupational exposure band (OEB) 3 and 4 drugs. 

GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. Plus, we perform tests and trial runs to demonstrate the functionality of all components and equipment before the plant is delivered.

Protecting the health and safety of your operators is paramount. With GEA, that’s a given. At the same time, we can also help you to maximize yields, prevent expensive product loss and reduce cycle times. Contact us today to discuss state-of-the-art, PPE-free containment solutions: from powder handling interfaces to compression and pellet coating, and from HVAC to washing and sterilization systems. 

Продукты и технологии

Показ {{count}} из {{total}}

Будьте в курсе инноваций и историй GEA, подписавшись на новостную рассылку от GEA.


Мы всегда готовы помочь! Пожалуйста, сообщите некоторые данные и мы предоставим ответ на Ваш запрос.

Свяжитесь с нами